IMA - ikenaoncology.com Enterprise Value
ImageneBio Inc (IMA) operations are constrained by global patenting complexities and raw material supply chain risks stemming from political conflicts. The market dynamics of the business's enterprise value (EV), as reflected in the price action, currently prices in -85.71. ImageneBio Inc (IMA) is minimizing losses by developing targeted antitumor agents for various patient groups, while its laboratories continue to operate seamlessly through regular technical upgrades.
Analytical breakdowns for ImageneBio Inc
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:IMA (ImageneBio Inc)
Comparative asset analysis requires evaluating a business beyond its market capitalization. This metric aggregates equity value and net debt to determine the actual cost of acquiring a company. For ImageneBio Inc (IMA), such expenses include investments in laboratory environmental upgrades and filtration systems. This approach separates fundamental value from market volatility. The price action of the indicative enterprise value confirms the objective value of the business.
Who ImageneBio Inc competes with
Real Price to Acquire Entire Company argenx N.V. ARGX|BioNTech Group - Enterprise Value|ABVX: Enterprise Value|Total Company Value ADMA Biologics (ADMA)|protagonist-inc.com (PTGX) - Full Business Value|IMVT - Enterprise Value|Value Adjusted for Debt and Cash Kiniksa Pharmaceuticals, Ltd.|Enterprise Value GRFS|Enterprise Value ADPT (Adaptive Biotechnologies Inc.)|Total Company Value Celldex Therapeutics|auriniapharma.com - Value Adjusted for Debt and Cash|BCRX: Total Company Value|VERA - Real Price to Acquire Entire Company|DNTH: Enterprise Value|Enterprise Value Pharvaris Pharma|ABCL - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash tourmalinebio.com|PGEN (Precigen) - Enterprise Value|Company Buyout Price PHAR (Pharming Group NV)|Nektar - Total Company Value|Upstream Pharma - Real Price to Acquire Entire Company|ZBIO: Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharma) - Enterprise Value|Total Company Value Septerna Corp (SEPN)|Business Value Pieris Corp|Savara Inc. - Enterprise Value|Total Enterprise Value rigel.com (RIGL)|Enterprise Value ANAB|Astria Therapeutics Inc - Company Buyout Price|ENGN: Total Company Value|RAPT - Real Price to Acquire Entire Company|JBIO: Enterprise Value|aclaristx.com (ACRS) - Enterprise Value|Kyverna Therapeutics, Inc. - Enterprise Value|Full Takeover Company Value Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Enterprise Value|Total Enterprise Value VTYX (Ventyx Biosciences, Inc)|THTX - Total Company Value|Business Value avalotx.com AVTX|ELDN (Eledon Pharmaceuticals, Inc.) - Enterprise Value|AGEN - Total Enterprise Value|Climb Bio, Inc. (CLYM) - Enterprise Value|Zura Bio Ltd (ZURA) - Total Company Value|ATYR: Enterprise Value|Company Buyout Price ADAG|Shattuck Labs, Inc. - Total Company Value|Total Enterprise Value equilliumbio.com EQ|Real Price to Acquire Entire Company Connect Biopharma Holdings Limited|Value Adjusted for Debt and Cash Immunic Therapeutics IMUX|Enterprise Value ATRA (Atara Biotherapeutics Inc)|IFRX: Company Buyout Price|Total Company Value X4 Pharmaceuticals, Inc.|Adicet Bio, Inc. (ACET) - Business Value|Enterprise Value CELU|Real Price to Acquire Entire Company INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - Enterprise Value|Company Buyout Price KZR (kezarlifesciences.com)|SAB Biotherapeutics, Inc. - Total Company Value|Real Price to Acquire Entire Company Akari Therapeutics PLC AKTX|Enlivex Therapeutics, Ltd. - Enterprise Value|QTTB: Enterprise Value|Total Company Value GeoVax Labs, Inc. (GOVX)|edesabiotech.com (EDSA) - Full Business Value|IBIO - Enterprise Value|Value Adjusted for Debt and Cash Carisma Tx|Enterprise Value XTLB|Enterprise Value BOLT (boltbio.com)|Total Company Value HCW Biologics|Aptevo Therapeutics, Inc. - Value Adjusted for Debt and Cash|AIM: Total Company Value|ADTX - Real Price to Acquire Entire Company|GRI: Enterprise Value|Enterprise Value XORTX Corp|HIND - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash revbiosciences.com|INDP (Indaptus Therapeutics, Inc.) - Enterprise Value|Company Buyout Price SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|Affimed NV - Real Price to Acquire Entire Company|ALLK: Total Company Value|HOOKIPA Pharma Inc. (HOOK) - Real Price to Acquire Entire Company|IGMS: Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Enterprise Value|Total Company Value Ocean Bio (OCEA)|Business Value TC BioPharm Ltd|Third Harmonic Bio - Enterprise Value